 To describe baseline characteristics of the Vitamin D and Type 2 Diabetes ( D2d) study , the first large U.S. diabetes prevention clinical trial to apply current American Diabetes Association ( ADA) criteria for prediabetes. This is a multicenter ( A total of 2,423 participants ( 45 % of whom were women and 33 % nonwhite) were randomized to cholecalciferol or placebo. Mean ( SD) age was 59 ( 9.9) years and BMI 32 ( 4.5) kg/m D2d will establish whether vitamin D supplementation lowers risk of diabetes and will inform about the natural history of prediabetes per contemporary ADA criteria.